University Hospital, Basel, Switzerland

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University Hospital, Basel, Switzerland sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 4 currently recruiting 3 completed top decile by trial count

University Hospital, Basel, Switzerland: 12 sponsored US clinical trials, 4 recruiting.

University Hospital, Basel, Switzerland sponsors 12 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Breast Cancer, with 2 trials.

Top-decile sponsor footprint

University Hospital, Basel, Switzerland ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

12 total, page 1 of 1

RECRUITING NA

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

NCT07140172
RECRUITING NA

The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema

NCT05890677
RECRUITING

Risk of Recurrent CeAD After Pregnancy

NCT06258109
RECRUITING NA

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

NCT03513614
ACTIVE NOT RECRUITING

The OPBC-07/microNAC Study

NCT06529302
ACTIVE NOT RECRUITING NA

ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS

NCT05458908
ACTIVE NOT RECRUITING NA

Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI)

NCT05649384
ACTIVE NOT RECRUITING NA

Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC

NCT04293146
ACTIVE NOT RECRUITING

BAsel Syncope EvaLuation (BASEL IX) Study

NCT01548352
COMPLETED

Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study

NCT06464341
COMPLETED

Validation Study of ClassIntra®

NCT03009929
COMPLETED NA

Intrusive Reexperiencing: The Role of Working Memory Capacity and Thought Suppression

NCT01007682

Therapeutic Areas

Breast Cancer 2
Risk Management 1
Intraoperative Complications 1
Implant-Based Breast Reconstruction (IBBR) 1
Acute Chest Pain 1
Cervical Artery Dissection 1
Syncope 1
Patient Safety 1
NSTEMI - Non-ST Segment Elevation MI 1
Lymphedema, Breast Cancer 1

What is open in the University Hospital, Basel, Switzerland pipeline

4 recruiting of 12 indexed (33% open); 3 completed (25%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Breast Cancer (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University Hospital, Basel, Switzerland: open-pipeline peers nationwide

Peers matched on 12 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

University Hospital, Basel, Switzerland sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 2468101214 0%10%20%30%40% Total trials Recruiting share University Hospital, Basel, SwitzerlandAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAadi BioscienceAaron CookAbivax S.A.Actuated Medical
University Hospital, Basel, Switzerland sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University Hospital, Basel, Switzerland sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University Hospital, Basel, Switzerland page

12 registered trials is a research-attention snapshot, not an endorsement of University Hospital, Basel, Switzerland or any single study.

  • 4 of University Hospital, Basel, Switzerland's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Breast Cancer is the condition University Hospital, Basel, Switzerland studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University Hospital, Basel, Switzerland pipeline card: 12 registered trials from official public datasets.Report a data error.